Adults 21+ worldwide can now join the Global Psychedelic Survey 2025—the most comprehensive assesment of psychedelic use amongst adults to date!. It will be available online from May 1–16, 2025. Access here:

Last month we held our virtual meeting! . It was a great opportunity to exchange on psychedelic science with experts from around the world. Thanks to all sponsors, speakers, and attendees for making it a success!. Here are some highlights. See you next year in New Orleans!

RT @psilera: Psilera enjoyed the insights shared at last week’s @ISRPsychedelics annual conference. It’s exciting to learn about developmen….

Philippe is a Research Affiliate at the Michigan Psychedelic Center. He's a longtime cannabis & psychedelic researcher and currently lead investigator on global psychedelic surveys. Talk: Co-use of psychedelics with other substances: findings from the global psychedelic survey

David is a postdoc. research fellow at the Center for Psychedelic and Consciousness Research at JHU, where he is leading a multi-study investigation of psychedelics and the role of music in set and setting (PRoMiSS). Talk: Psychedelics and psychological strengths.

Talk: The Open Psilocybin Evaluation Nexus (OPEN): Initial Findings from a Practice-Based Research Network on State-Regulated Psilocybin Services.

Jason is Dir. of Research at Portland Institute for Psychedelic Science, and CEO of Portland Psychotherapy  Clinic, Research, & Training Center. He is also Associate Scientist at the Oregon Research Institute and affiliate faculty at the Oregon Health Sciences University.

Kevin is Associate Prof. at LSU (Pharmacology, Toxicology & Neuroscience; Psychiatry & Behavioral Medicine). His research focuses on the etiology & treatment of CNS disorders. 🧠💊. Talk: Exploring the Potential of Psychedelics as a Treatment for Methamphetamine Addiction.

Guillermo is a PhD student at the University of the Republic, Uruguay, studying Uruguayan psilocybin-producing fungi diversity and their alkaloid content. 🍄🔬. Talk: As Time Goes By: The Impact of Drying & Preservation Methods on Mushroom Tryptamine Content.

🚨 Just 2 days until our conference! 🚨. We're excited to introduce more of our amazing speakers: Guillermo Morera, Kevin Murnane, Jason Luoma, David Rosen, and Philippe Lucas! 🎤✨. Don't miss out—registrations are still open! 🔗 1/6

Luisina, is a graduate student at the Faculty of Chemistry (UDELAR), Uruguay. She currently studies secondary metabolites in several genera of fungi. Talk: Determination of Psilocin and Psilocybin by Quantitative Nuclear Magnetic Resonance in Psychedelic Mushrooms from Uruguay.

Grant is a staff research fellow in the Designer Drug Research Unit of the National Institute on Drug Abuse. Talk: Serotonin transporter activity modulates the psychedelic-like effects of 4-methoxy-N-methyl-N-isopropyltryptamine and related analogs in mice.

Agnieszka is a PhD student at the Maj Institute of Pharmacology, curryently studying the effects of psilocybin, 25I-NBOMe, and ketamine in chronic mild stress models. Talk: Psilocybin's effect on monoaminergic and amino acid neurotransmitter release in chronically stressed rats.

Sophie recently earned her MSc from Maastricht University. For her PhD she aims to study antidepressant treatments and biomarkers of depression. Talk: Pre-Administration of Lorazepam Negates the Antidepressant-like Effects of Psilocybin in Male Wistar Kyoto Rats.

Meet more of this year’s amazing conference speakers! We're thrilled to introduce Sophie Woodruff, Grant Glatfelter, Agnieszka Bysiek, Luisina Rodriguez. 👇

RT @JHPsychedelics: The International Society for Research on Psychedelics (ISRP) is hosting their conference virtually this year on March….

RT @ISRPsychedelics: 🚨 Exciting news! 🚨.We’re thrilled to announce the schedule & speaker lineup for our virtual conference on March 7, 202….

Join us this monday!.

Applications for our registration awards, sponsored by @Psyched_Alpha , are still open!. To apply, access this link:

Dr. Damaj is Professor of Pharmacology and Toxicology at Virginia Commonwealth University and Co-Director of the Translational Research Initiative for Pain and Neuropathy (TRIPN) at VCU. His talk: “The Classical Psychedelic Psilocybin Mitigates Oxycodone Withdrawal”. Mariana.